Clinical-stage ophthalmology biotechnology company EyeBio has announced first dosing of participants with an investigational treatment for neovascular age-related macular degeneration (nAMD) and diabetic macular

There are promising signs that an industry-first initiative, bringing together patient support bodies from across Australia and Aotearoa New Zealand, will result in strategies

They’re a marine delicacy loved across Asia, but the sea cucumber is also proving to be a key ingredient in preventing diabetes, according to

Visitors to the Glaucoma Australia website can now access a wide range of accessibility and language support tools to customise their digital experience through